Close Menu

herpes

By a GenomeWeb staff reporter


NEW YORK (GenomeWeb News) – BioHelix today announced that the US Food and Drug Administration has given 510(k) clearance for its assay for the detection of herpes simplex virus.

Medical Diagnostic Lab has been awarded US Patent No. 8,030,032, "Methods and compositions related thereto for detecting and identifying distinct species of nucleic acids from causative agents."

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – EraGen Biosciences today announced the US Food and Drug Administration has cleared its MultiCode-RTx HSV 1&2 kit for use on bioMérieux's NucliSens easyMag extraction system.

Akonni will use the grant to develop a closed amplicon RT-PCR microarray for detecting enterovirus, herpes viruses, and West Nile virus in cerebral spinal fluid.

In addition, Argene will provide BioMérieux with a portfolio of molecular tests for diagnosing infectious diseases in transplant and other immunocompromised patients.

BioMérieux plans to migrate Argene's test products onto a molecular diagnostic platform it is co-developing with Biocartis.

According to BD, the BD ProbeTec Herpes Simplex Viruses Qx Amplified DNA Assays are the first automated molecular assays for the detection and differentiation of HSV types 1 and 2 in clinician-collected external anogenital specimens.

The BD ProbeTec HSV-1 and HSV-2 Qx Amplified DNA assays are the first fully automated molecular tests for HSV types 1 and 2.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.